Elsa Lilienberg

Elsa Lilienberg, PhD, is Senior Consultant in drug development at Cytel. With more than 10 years of experience in preclinical and clinical research, both in academia and the pharmaceutical industry, she is an expert in drug metabolism, pharmacokinetics and clinical pharmacology.  

Before joining Cytel, Elsa held a position within regulatory affairs at a mid-size pharmaceutical company with the key responsibilities to manage clinical trial applications, preclinical studies and to act as pharmacokinetic expert for preclinical and clinical development. Elsa enjoys strategic thinking, writing regulatory scientific documents, and authoring scientific responses to questions from regulators. She has so far been involved in more than five drug applications that have resulted in approval (nationally or within the EU). Moreover, she has experience working with health authorities globally (mainly within the EU) and has participated in scientific meetings with the EMA and FDA.